サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1439676

頭蓋内出血（ICH）デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Intracranial Hemorrhage Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
頭蓋内出血（ICH）デバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の頭蓋内出血（ICH）デバイスの市場規模は、2023年に15億9,000万米ドル、2030年までに23億5,000万米ドルに達し、2024年～2030年の予測期間にCAGRで6.65％の成長が見込まれます。頭蓋内出血（ICH）デバイス需要の増加は主に、脳卒中、脳/脳動脈瘤などの脳障害の患者の増加、脳障害を患う老年人口の負担の増加、先進技術を利用したICHデバイスの開発への焦点のシフトによるものであり、2024年～2030年の予測期間に頭蓋内出血（ICH）デバイス市場の成長に寄与します。

頭蓋内出血（ICH）デバイスの市場力学

頭蓋内出血（ICH）デバイス市場は、さまざまな理由によって製品需要が伸びています。製品需要の主な要因は、世界中での脳卒中、脳動脈瘤、頭蓋内狭窄症などの脳障害を患う患者の負担の増加によるものであり、これらのデバイスは低侵襲の脳神経手術技法を使用して脳のさまざまな状態や疾患を治療するのに使用されることから、頭蓋内出血（ICH）デバイスの需要を促進すると予測されています。

例えば、Brain Aneurysm Foundation（2020）の統計によると、脳動脈瘤が原因で死亡する人は世界で毎年50万人近くおり、犠牲者の半数は50歳未満で、特に55歳以上の女性は男性よりも脳動脈瘤破裂のリスクが高い（約1.5倍）です。

同調査によると、米国では推定650万人が未破裂の脳動脈瘤を抱えています。

さらに、World Stroke Organization（2022）によると、世界全体で25歳以上の成人の4人に1人が生涯に脳卒中を発症するとされています。世界で毎年1,370万人が初めて脳卒中を発症し、その結果550万人が死亡します。また、同統計によれば、脳卒中は世界の死亡および障害の主因であり、毎年1億1,600万年の健康寿命がこの疾患によって失われています。

このように、対象人工の増加により脳手術の需要が高まり、予測期間に頭蓋内出血（ICH）デバイスの需要が増加すると見込まれます。

そのため、適切なモニタリングにより、適切なケアと投薬治療を受けることで、これらの欠陥を予防することができます。したがって、頭蓋内出血（ICH）デバイス市場の成長は、2024年～2030年の予測期間に伸びる見込みです。

しかし、頭蓋内出血（ICH）デバイスに伴うリスクや、デバイスや手術の高いコストが、頭蓋内出血（ICH）デバイス市場の成長の一定の抑制要因となる可能性があります。

市場は、頭蓋内出血（ICH）デバイスの使用に影響を与えるCOVID-19の発生に直面しました。頭蓋内出血は非常に希少ではありますが、COVID-19の合併症としてよく知られています。脳卒中はCOVID-19の症状として認められ、COVID-19患者の0.9％～23％が脳卒中を発症したことがさまざまな研究で示されています。COVID-19患者は血栓形成促進状態にあり、血液が濃くなったり粘着性になったりする傾向があるため、脳に血液を供給する血管が閉塞し、脳の特定部分の血液供給が遮断されて脳梗塞の症状が現れます。その結果、頭蓋内出血（ICH）デバイスの需要が増加しました。

頭蓋内出血（ICH）デバイス市場のセグメント分析

頭蓋内出血（ICH）デバイス市場の製品タイプセグメントでは、予測期間（2024年～2030年）に神経内視鏡が市場で高いシェアを占める見込みです。これは、これらのデバイスが持つ脳のモニタリングに向けたさまざまな利点によるものと考えられます。これらのデバイスは低侵襲技術であり、外科医が頭蓋骨の内側に位置するために以前は手術不可能と考えられていた脳内の腫瘍やその他の問題領域に到達するのに役立ちます。

さらに、神経内視鏡検査は鼻のような生来の身体の開口部から行うことができるため、大きな切開を必要としません。これらの内視鏡の先端にはライトとカメラが付いており、手術のために脳内をよりよく可視化するのに役立つなどの利点があります。

当レポートでは、世界の頭蓋内出血（ICH）デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 頭蓋内出血（ICH）デバイス市場レポートのイントロダクション

第2章 頭蓋内出血（ICH）デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 頭蓋内出血（ICH）デバイス市場の主な要因の分析

  • 頭蓋内出血（ICH）デバイス市場の促進要因
    • 脳卒中、脳/脳動脈瘤などの脳障害の患者の増加
    • 脳障害を患う老年人口の負担の増大
    • 先進技術を利用したICHデバイスの開発への焦点のシフト
  • 頭蓋内出血（ICH）デバイス市場の抑制要因と課題
    • 頭蓋内出血（ICH）デバイスに伴うリスク
    • デバイスと手術の高いコスト
  • 頭蓋内出血（ICH）デバイス市場の機会
    • 脳への危険な影響を排除する先進のデバイスの開発
    • 専用の頭蓋内出血（ICH）デバイスの開発へのニーズの高まり

第5章 頭蓋内出血（ICH）デバイス市場のポーターのファイブフォース分析

第6章 頭蓋内出血（ICH）デバイス市場に対するCOVID-19の影響分析

第7章 頭蓋内出血（ICH）デバイス市場のレイアウト

  • 製品タイプ別
    • 診断
    • 治療
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 頭蓋内出血（ICH）デバイス市場：世界の企業シェア分析 - 主要3～5社

第9章 頭蓋内出血（ICH）デバイス市場の企業と製品のプロファイル

  • ClearMind Biomedical Inc.
  • Medtronic
  • Stryker
  • InfraScan, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Acandis GmbH
  • Cerenovus (Johnson & Johnson Services, Inc.)
  • MicroVention Inc. (Terumo Corporation)
  • Invamed
  • B. Braun Melsungen AG
  • adeor medical AG
  • SCHINDLER Endoskopie Technologie
  • Siemens Healthcare GmbH
  • CANON MEDICAL SYSTEMS CORPORATION
  • Kaneka Medix Corporation
  • Hyperfine
  • General Electric Company
  • phenox GmbH
  • Perflow Medical Ltd.

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Intracranial Hemorrhage (ICH) Devices Market in Global (2021-2030)
  • Table 4: Intracranial Hemorrhage (ICH) Devices Market in Global by Product Type (2021-2030)
  • Table 5: Intracranial Hemorrhage (ICH) Devices Market in Global by End User (2021-2030)
  • Table 6: Intracranial Hemorrhage (ICH) Devices Market in Global by Geography (2021-2030)
  • Table 7: Intracranial Hemorrhage (ICH) Devices Market in North America (2021-2030)
  • Table 8: Intracranial Hemorrhage (ICH) Devices Market in North America by Country (2021-2030)
  • Table 9: Intracranial Hemorrhage (ICH) Devices Market in the US (2021-2030)
  • Table 10: Intracranial Hemorrhage (ICH) Devices Market in Canada (2021-2030)
  • Table 11: Intracranial Hemorrhage (ICH) Devices Market in Mexico (2021-2030)
  • Table 12: Intracranial Hemorrhage (ICH) Devices Market in Europe (2021-2030)
  • Table 13: Intracranial Hemorrhage (ICH) Devices Market in Europe by Country (2021-2030)
  • Table 14: Intracranial Hemorrhage (ICH) Devices Market in France (2021-2030)
  • Table 15: Intracranial Hemorrhage (ICH) Devices Market in Germany (2021-2030)
  • Table 16: Intracranial Hemorrhage (ICH) Devices Market in the United Kingdom (2021-2030)
  • Table 17: Intracranial Hemorrhage (ICH) Devices Market in Italy (2021-2030)
  • Table 18: Intracranial Hemorrhage (ICH) Devices Market in Spain (2021-2030)
  • Table 19: Intracranial Hemorrhage (ICH) Devices Market in Russia (2021-2030)
  • Table 20: Intracranial Hemorrhage (ICH) Devices Market in Rest of Europe (2021-2030)
  • Table 21: Intracranial Hemorrhage (ICH) Devices Market in APAC (2021-2030)
  • Table 22: Intracranial Hemorrhage (ICH) Devices Market in APAC by Country (2021-2030)
  • Table 23: Intracranial Hemorrhage (ICH) Devices Market in China (2021-2030)
  • Table 24: Intracranial Hemorrhage (ICH) Devices Market in Japan (2021-2030)
  • Table 25: Intracranial Hemorrhage (ICH) Devices Market in India (2021-2030)
  • Table 26: Intracranial Hemorrhage (ICH) Devices Market in Australia (2021-2030)
  • Table 27: Intracranial Hemorrhage (ICH) Devices Market in South Korea (2021-2030)
  • Table 28: Intracranial Hemorrhage (ICH) Devices Market in Rest of APAC (2021-2030)
  • Table 29: Intracranial Hemorrhage (ICH) Devices Market in Rest of World (2021-2030)
  • Table 30: Intracranial Hemorrhage (ICH) Devices Market in RoW by Region (2021-2030)
  • Table 31: Intracranial Hemorrhage (ICH) Devices Market in Middle East (2021-2030)
  • Table 32: Intracranial Hemorrhage (ICH) Devices Market in Africa (2021-2030)
  • Table 33: Intracranial Hemorrhage (ICH) Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Intracranial Hemorrhage (ICH) Devices Market in Global (2021-2030)
  • Figure 4: Intracranial Hemorrhage (ICH) Devices Market in Global by Product Type (2021-2030)
  • Figure 5: Intracranial Hemorrhage (ICH) Devices Market in Global by End User (2021-2030)
  • Figure 6: Intracranial Hemorrhage (ICH) Devices Market in Global by Geography (2021-2030)
  • Figure 7: Intracranial Hemorrhage (ICH) Devices Market in North America (2021-2030)
  • Figure 8: Intracranial Hemorrhage (ICH) Devices Market in North America by Country (2021-2030)
  • Figure 9: Intracranial Hemorrhage (ICH) Devices Market in the US (2021-2030)
  • Figure 10: Intracranial Hemorrhage (ICH) Devices Market in Canada (2021-2030)
  • Figure 11: Intracranial Hemorrhage (ICH) Devices Market in Mexico (2021-2030)
  • Figure 12: Intracranial Hemorrhage (ICH) Devices Market in Europe (2021-2030)
  • Figure 13: Intracranial Hemorrhage (ICH) Devices Market in Europe by Country (2021-2030)
  • Figure 14: Intracranial Hemorrhage (ICH) Devices Market in France (2021-2030)
  • Figure 15: Intracranial Hemorrhage (ICH) Devices Market in Germany (2021-2030)
  • Figure 16: Intracranial Hemorrhage (ICH) Devices Market in the United Kingdom (2021-2030)
  • Figure 17: Intracranial Hemorrhage (ICH) Devices Market in Italy (2021-2030)
  • Figure 18: Intracranial Hemorrhage (ICH) Devices Market in Spain (2021-2030)
  • Figure 19: Intracranial Hemorrhage (ICH) Devices Market in Russia (2021-2030)
  • Figure 20: Intracranial Hemorrhage (ICH) Devices Market in Rest of Europe (2021-2030)
  • Figure 21: Intracranial Hemorrhage (ICH) Devices Market in APAC (2021-2030)
  • Figure 22: Intracranial Hemorrhage (ICH) Devices Market in APAC by Country (2021-2030)
  • Figure 23: Intracranial Hemorrhage (ICH) Devices Market in China (2021-2030)
  • Figure 24: Intracranial Hemorrhage (ICH) Devices Market in Japan (2021-2030)
  • Figure 25: Intracranial Hemorrhage (ICH) Devices Market in India (2021-2030)
  • Figure 26: Intracranial Hemorrhage (ICH) Devices Market in Australia (2021-2030)
  • Figure 27: Intracranial Hemorrhage (ICH) Devices Market in South Korea (2021-2030)
  • Figure 28: Intracranial Hemorrhage (ICH) Devices Market in Rest of APAC (2021-2030)
  • Figure 29: Intracranial Hemorrhage (ICH) Devices Market in Rest of World (2021-2030)
  • Figure 30: Intracranial Hemorrhage (ICH) Devices Market in RoW by Region (2021-2030)
  • Figure 31: Intracranial Hemorrhage (ICH) Devices Market in Middle East (2021-2030)
  • Figure 32: Intracranial Hemorrhage (ICH) Devices Market in Africa (2021-2030)
  • Figure 33: Intracranial Hemorrhage (ICH) Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0516

Intracranial Hemorrhage (ICH) Devices Market By Product Type (Diagnosis [Neuroendoscopes, Ct, Mri, Others], Treatment [Embolization Devices, Intracranial Stents, Balloon Occlusion Devices, Neurothrombectomy Devices, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising cases of brain disorders and growing geriatric population

Global Intracranial Hemorrhage (ICH) Devices Market was valued at USD 1.59 Billion in 2023, growing at a CAGR of 6.65% during the forecast period from 2024 to 2030 to reach USD 2.35 Billion by 2030. The increase in demand for Intracranial Hemorrhage (ICH) Devices is primarily attributed to the rising cases of brain disorders such as Stroke, Cerebral/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices, thereby contributing to the growth of the Intracranial Hemorrhage (ICH) Devices market during the forecast period from 2024-2030.

Intracranial Hemorrhage (ICH) Devices Market Dynamics:

The Intracranial Hemorrhage (ICH) Devices market is witnessing a growth in product demand owing to various reasons. The major reason responsible for product demand is due to the rising burden of the patient population suffering from brain disorders such as Stroke, Cerebral/Brain Aneurysm, Intracranial Stenosis, among others across the globe is expected to fuel the demand for Intracranial hemorrhage (ICH) Devices as these devices are used to treat various conditions and diseases of the brain using minimally invasive neurosurgical techniques.

For instance, according to the statistics of Brain Aneurysm Foundation 2020, there are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50, and women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk).

As per the same study, an estimated 6.5 million people in the United States have an un-ruptured brain aneurysm.

Moreover, according to the World Stroke Organization 2022, globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. 13.7 million people worldwide will have their first stroke each year and five and a half million will die as a result. Also, as per the same statistics, stroke is the leading cause of death and disability globally with 116 Million years of healthy life lost each year to the disease.

Thus, the rising prevalence of the target population is anticipated to raise the demand for brain surgeries thereby increasing the demand for Intracranial hemorrhage (ICH) Devices during the forecasted period.

Therefore, with proper monitoring, these defects can be prevented by undergoing proper care and medication. Hence, the growth of the Intracranial hemorrhage (ICH) Devices Market is expected to rise during the forecast period from 2024 to 2030.

However, the risk involved with Intracranial Hemorrhage (ICH) Devices and the high cost of equipment and surgeries may be certain limiting factors of the Intracranial Hemorrhage (ICH) Devices market growth.

The market witnessed a COVID-19 outbreak which impacted the use of Intracranial hemorrhage (ICH) Devices. Intracerebral hemorrhage is a very rare but well-documented complication of COVID-19. Stroke has been seen as a manifestation of COVID-19 in various studies showing that 0.9% to 23% of COVID-19 patients developed brain stroke. COVID-19 patients have a prothrombotic state which means they tend for the blood to thicken or become sticky which blocks the blood vessels supplying the brain; the blood supply of a particular part of the brain is cut off resulting in stroke symptoms. This resulted in the increased demand for Intracranial hemorrhage (ICH) Devices.

Intracranial Hemorrhage (ICH) Devices Market Segment Analysis:

Intracranial Hemorrhage (ICH) Devices Market By Product Type (Diagnosis [Neuroendoscopes, CT, MRI, Others], Treatment [Embolization Devices, Intracranial Stents, Balloon Occlusion Devices, Neurothrombectomy Devices, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Intracranial Hemorrhage (ICH) Devices market, the Neuroendoscopes are estimated to hold a higher share in the Intracranial Hemorrhage (ICH) Devices market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices for the monitoring of the brain. These devices are minimally invasive techniques and help surgeons to reach tumors and other problematic areas inside the brain, previously considered inoperable due to their position inside the skull.

Moreover, since neuroendoscopy may be performed through natural body openings, such as the nose, it prevents the need for large incisions. Advantageous properties such as these endoscopes have a light and camera on the end, which helps in better visualization inside the brain for the surgery.

Moreover, the research and development activities in this arena will in turn drive the product demand in the market. For instance, in a clinical study, surgeons attached a fully charged smartphone to the front of a neuroendoscope, this provided visualization of the surgical field for use in minimally invasive neurosurgery.

Therefore, the advantages offered by the Neuroendoscopes such as minimal invasiveness, lower blood loss, and shorter surgical time in Intracranial hemorrhage surgeries are predicted to contribute to the increasing demand of the Intracranial hemorrhage (ICH) Devices market.

North America is expected to dominate the overall Intracranial Hemorrhage (ICH) Devices Market:

Among all the regions, North America is expected to account for the largest share in the global Intracranial Hemorrhage (ICH) Devices market. Factors such as the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, rising incidences of intracranial hemorrhage are expected to aid in the growth of the North America Intracranial hemorrhage (ICH) Devices Market.

As per the Brain Aneurysm Foundation 2020, about 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. African-Americans and Hispanics are about twice as likely to have a brain aneurysm rupture compared to whites.

Moreover, the rising product approvals and new technologies such as the integration of AI in these devices in the country will boost the growth of the market.

For instance, in November 2022, FUJIFILM Healthcare Americas Corporation's REiLI® Artificial Intelligence Platform was used for clinical purposes for intracranial hemorrhage.

Therefore, the rising prevalence of these defects in the country would result in the rising demand for treatments that make use of Intracranial hemorrhage (ICH) Devices, which in turn would provide a conducive growth environment for the United States Intracranial hemorrhage (ICH) Devices market as well as the North American region.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Intracranial hemorrhage (ICH) Devices market during the forecast period.

Intracranial Hemorrhage (ICH) Devices Market Key Players:

Some of the key market players operating in the Intracranial Hemorrhage (ICH) Devices market include ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd., among others.

Recent Developmental Activities in the Intracranial Hemorrhage (ICH) Devices Market:

In February 2022, the FDA granted expanded indication to Infrascanner, a handheld device used for detecting traumatic supratentorial hematomas in adults, to include pediatric patients aged 2 years and older.

In May 2019, Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the U.S. Food and Drug Administration (FDA).

Key Takeaways from the Intracranial Hemorrhage (ICH) Devices Market Report Study

  • Market size analysis for current Intracranial Hemorrhage (ICH) Devices market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Intracranial Hemorrhage (ICH) Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Intracranial Hemorrhage (ICH) Devices market.
  • Various opportunities available for the other competitor in the Intracranial Hemorrhage (ICH) Devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Intracranial Hemorrhage (ICH) Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Intracranial Hemorrhage (ICH) Devices market growth in the coming future?

Target Audience who can be benefited from this Intracranial Hemorrhage (ICH) Devices Market Report Study

  • Intracranial Hemorrhage (ICH) Devices products providers
  • Research organizations and consulting companies
  • Intracranial Hemorrhage (ICH) Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Intracranial Hemorrhage (ICH) Devices
  • Various End-users who want to know more about the Intracranial Hemorrhage (ICH) Devices market and latest technological developments in the Intracranial Hemorrhage (ICH) Devices market.

Frequently Asked Questions For Intracranial Hemorrhage (ICH) Devices Market:

1. What are Intracranial Hemorrhage (ICH) Devices?

Intracranial hemorrhage encompasses four broad types of hemorrhage: epidural hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, and intraparenchymal hemorrhage and ICH devices are medical devices used to diagnose and treat these dir=sorders.

2. What is the market for Global Intracranial Hemorrhage (ICH) Devices?

Global Intracranial Hemorrhage (ICH) Devices Market was valued at USD 1.5 Billion in 2023, growing at a CAGR of 6.65% during the forecast period from 2024 to 2030 to reach USD 2.35 Billion by 2030.

3. What are the drivers for the Global Intracranial Hemorrhage (ICH) Devices Market?

The Intracranial Hemorrhage (ICH) Devices market is witnessing a positive market growth owing to the rising cases of brain disorders such as Stroke, Cerebral/Brain Aneurysm, the growing burden of the old age population suffering from brain disorders, shifting focus towards the development of technologically advanced ICH Devices are anticipated to bolster the market.

4. Who are the key players operating in the Global Intracranial Hemorrhage (ICH) Devices Market?

Some of the key market players operating in the Intracranial Hemorrhage (ICH) Devices market include ClearMind Biomedical Inc., Medtronic, Stryker, InfraScan, Inc., MicroPort Scientific Corporation, Penumbra, Inc., Acandis GmbH, Cerenovus (Johnson & Johnson Services, Inc.), MicroVention Inc. (Terumo Corporation), Invamed, B. Braun Melsungen AG, adeor medical AG, SCHINDLER Endoskopie Technologie, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Kaneka Medix Corporation, Hyperfine, General Electric Company, phenox GmbH, Perflow Medical Ltd. and others.

5. Which region has the highest share in Intracranial Hemorrhage (ICH) Devices Market?

North America is expected to hold the highest share in the revenue in the Intracranial Hemorrhage (ICH) Devices market during the forecast period. Factors such as the rising cases of brain disorders such as stroke, cerebral/brain aneurysm, rising incidences of intracranial hemorrhage are expected to aid in the growth of the North America Intracranial Hemorrhage (ICH) Devices Market in this region.

Table of Contents

1.Intracranial Hemorrhage (ICH) Devices Market Report Introduction

2.Intracranial Hemorrhage (ICH) Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Intracranial Hemorrhage (ICH) Devices Market Key Factors Analysis

  • 4.1. Intracranial Hemorrhage (ICH) Devices Market Drivers
    • 4.1.1. Rising Cases of Brain Disorders Such as Stroke, Cerebral/Brain Aneurysm
    • 4.1.2. Growing Burden of Old Age Population Suffering With Brain Disorders
    • 4.1.3. Shifting Focus Towards Development Of Technologically Advanced ICH Devices
  • 4.2. Intracranial Hemorrhage (ICH) Devices Market Restraints and Challenges
    • 4.2.1. The Risk involved with Intracranial hemorrhage (ICH) Devices
    • 4.2.2. The High Cost of Equipment and Surgeries
  • 4.3. Intracranial Hemorrhage (ICH) Devices Market Opportunities
    • 4.3.1. Development of Advanced Devices that Eliminates the Risky Effects on the Brain
    • 4.3.2. Rising Need for Developing Specific Intracranial Hemorrhage (ICH) Devices

5. Intracranial Hemorrhage (ICH) Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Intracranial Hemorrhage (ICH) Devices Market

7. Intracranial Hemorrhage (ICH) Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Diagnosis
      • 7.1.1.1. Neuroendoscopes
      • 7.1.1.2. CT
      • 7.1.1.3. MRI
      • 7.1.1.4. Others
    • 7.1.2. Treatment
      • 7.1.2.1. Embolization Devices
      • 7.1.2.2. Intracranial Stents
      • 7.1.2.3. Balloon Occlusion Devices
      • 7.1.2.4. Neurothrombectomy Devices
      • 7.1.2.5. Others
  • 7.2. By End User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. North America Intracranial Hemorrhage (ICH) Devices Market, by Country
      • 7.3.1.1.1. United States
      • 7.3.1.1.2. Canada
      • 7.3.1.1.3. Mexico
    • 7.3.2. Europe
      • 7.3.2.1. Europe Intracranial Hemorrhage (ICH) Devices Market, by Country
      • 7.3.2.1.1. France
      • 7.3.2.1.2. Germany
      • 7.3.2.1.3. United Kingdom
      • 7.3.2.1.4. Italy
      • 7.3.2.1.5. Spain
      • 7.3.2.1.6. Russia
      • 7.3.2.1.7. Rest of Europe
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. Asia-Pacific Intracranial Hemorrhage (ICH) Devices Market, by Country
      • 7.3.3.1.1. China
      • 7.3.3.1.2. Japan
      • 7.3.3.1.3. India
      • 7.3.3.1.4. Australia
      • 7.3.3.1.5. South Korea
      • 7.3.3.1.6. Rest of Asia Pacific
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Intracranial Hemorrhage (ICH) Devices Market, by Region
      • 7.3.4.1.1. Middle East
      • 7.3.4.1.2. Africa
      • 7.3.4.1.3. South America

8. Intracranial Hemorrhage (ICH) Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Intracranial Hemorrhage (ICH) Devices Market Company and Product Profiles

  • 9.1. ClearMind Biomedical Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Medtronic
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Stryker
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. InfraScan, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. MicroPort Scientific Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Penumbra, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Acandis GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Cerenovus (Johnson & Johnson Services, Inc.)
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. MicroVention Inc. (Terumo Corporation)
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Invamed
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. B. Braun Melsungen AG
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. adeor medical AG
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. SCHINDLER Endoskopie Technologie
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Siemens Healthcare GmbH
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. CANON MEDICAL SYSTEMS CORPORATION
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Kaneka Medix Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Hyperfine
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. General Electric Company
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. phenox GmbH
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Perflow Medical Ltd.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us